Insmed Incorporated

Healthcare

NASDAQ:INSM · NASDAQ Global Select

Market Cap $21.21B Beta 0.77 P/E (TTM) -17.8

$97.85 +1.17%

+$1.13 today

52W Low $90.39High $212.75

Vol 4.52M · Avg 3.15M

EPS (TTM)-$5.49

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-0.89%

Period High

$211.41

Period Low

$91.88

Latest

$97.85

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Cardinal Health, Inc.

NYSE:CAH

$52.43B

Takeda Pharmaceutical Company Limited

NYSE:TAK

$50.27B

Humana Inc.

NYSE:HUM

$45.53B

Haleon plc

NYSE:HLN

$40.31B

Agilent Technologies, Inc.

NYSE:A

$36.67B

Alcon Inc.

NYSE:ALC

$32.58B

IQVIA Holdings Inc.

NYSE:IQV

$30.29B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

$29.65B

BeOne Medicines Ltd.

NASDAQ:ONC

$28.26B

ResMed Inc.

NYSE:RMD

$28.25B

What is the latest INSM filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does INSM have?

Intrinsic Alpha currently shows 20 recent filings for INSM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.